When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there’s not enough time to set off the cell’s alarm system.
Now, a Loyola University Chicago study has discovered the protein that helps the virus travel so fast. Researchers found that without this protein, the virus became stranded in the cytoplasm, where it was detected by the viral defense system. (The cytoplasm is the portion of the cell outside the nucleus.)
“By preventing its normal movement, we essentially turned HIV-1 into a sitting duck for cellular sensors,” said Edward M. Campbell, PhD, corresponding author of the study, published in the Proceedings of the National Academy of Sciences. Campbell is an associate professor in the Department of Microbiology and Immunology of Loyola University Chicago Stritch School of Medicine.
HIV-1 infects and kills immune system cells, including T cells and macrophages that were used in the study. This cripples the immune system, making the patient vulnerable to common bacteria, viruses and other pathogens that are usually harmless in people with healthy immune systems.
After HIV-1 enters a cell, it has to work its way through the cytoplasm to the nucleus. Once inside the nucleus, HIV-1 takes control of the cell and makes additional HIV-1 copies. But getting through the cytoplasm is not easy. Cytoplasm consists of fluid that is thick with proteins and structures such as mitochondria. “Something the size of a virus cannot just diffuse through the cytoplasm,” Campbell said. “It would be like trying to float to the bathroom in a very crowded bar. You need to have a plan.”
HIV-1 is able to get to the nucleus quickly via tubular tracks called microtubules. The virus attaches itself to a molecular motor called dynein, which moves down the microtubule like a train car on tracks.
Campbell and colleagues discovered the “ticket” HIV-1 needs to get on the train — a protein called bicaudal D2. HIV-1 binds to bicaudal D2, which recruits the dynein molecular motor. The dynein then transports HIV-1 towards the nucleus.
The finding raises the possibility of developing a drug that would prevent HIV-1 from binding to bicaudal D2, thus stranding the virus in the cytoplasm. This would not only prevent infection, but also give the cell time to turn on antiviral genes that would protect it and neighboring cells from infection.
Learn more: Study suggests a way to stop HIV in its tracks
The Latest on: HIV
- Understanding HIVon August 2, 2022 at 4:33 am
How have perceptions of HIV changed from the 1980s till now? Following the three-part documentary AIDS: The Unheard Tapes, Ben Hunte joins a special panel to discuss everything from dating and ...
- Our lives are not a crime: Why criminalisation and discrimination threaten to derail the fight against HIVon August 2, 2022 at 1:56 am
Today, advancements in HIV prevention and treatment have given us more ways than ever to prevent new infections and care for those living with HIV. Countries are moving to roll out new HIV prevention ...
- First Heart Transplant Performed Between HIV-Positive Donor, Recipienton August 1, 2022 at 4:58 pm
And in another HIV-related advance, doctors have announced that a 66-year-old man has been cleared of HIV through a stem cell transplant.
- Rape victim outraged suspect isn't required to have an HIV test after change to lawon August 1, 2022 at 2:30 pm
Prosecutors in Virginia used to be able to request rape suspects get tested but a change to the law has some people outraged including a woman who was recently sexually assaulted.
- 2 more people have been 'cured' of HIV — 1 man thanks to cancer treatment, and 1 woman who mysteriously developed natural control over the viruson August 1, 2022 at 12:33 pm
Two more patients were announced functionally "cured" of HIV during AIDS 2022. One had cancer, the other has naturally controlled the virus for years.
- COVID complicated HIV pandemic, but faith groups praised for responseon August 1, 2022 at 10:23 am
Leaders of the global response to HIV and AIDS who gathered in Montreal for the International AIDS Conference praised faith leaders for their contribution to fighting the four decade-old pandemic.
- Is There Accelerated Aging for Those With Living With HIV?on August 1, 2022 at 9:18 am
UCLA research Beth D. Jamieson explores the relationship between HIV and aging. Recent evidence suggests that HIV may accelerate aging within two or three years of the initial infection.
- HIV: Fourth, and oldest patient yet enters remission after cell transplanton August 1, 2022 at 9:00 am
The City of Hope hospital reports that the oldest patient yet has now achieved remission from HIV and leukemia after stem cell transplant treatment.
- Proposed policies and funding efforts could end HIV epidemic, experts sayon August 1, 2022 at 7:58 am
Researchers at the Johns Hopkins Bloomberg School of Public Health have contributed to a special issue of the Journal of Law, Medicine, and Ethics, including studies and commentary that support a ...
- Stem Cell Transplant Cures Man Of HIV, Blood Canceron August 1, 2022 at 6:53 am
A 66-year-old man is now cancer- and HIV-free after undergoing stem cell treatment at City of Hope in Los Angeles, a cancer research and treatment center.
via Google News and Bing News